JP2011509079A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509079A5
JP2011509079A5 JP2010540186A JP2010540186A JP2011509079A5 JP 2011509079 A5 JP2011509079 A5 JP 2011509079A5 JP 2010540186 A JP2010540186 A JP 2010540186A JP 2010540186 A JP2010540186 A JP 2010540186A JP 2011509079 A5 JP2011509079 A5 JP 2011509079A5
Authority
JP
Japan
Prior art keywords
cancer
antibody
affinity reagent
receptor
ephrin type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010540186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509079A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/003634 external-priority patent/WO2009087462A2/en
Publication of JP2011509079A publication Critical patent/JP2011509079A/ja
Publication of JP2011509079A5 publication Critical patent/JP2011509079A5/ja
Pending legal-status Critical Current

Links

JP2010540186A 2007-12-24 2008-12-24 エフリンａ型受容体１０タンパク質 Pending JP2011509079A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US877507P 2007-12-24 2007-12-24
PCT/IB2008/003634 WO2009087462A2 (en) 2007-12-24 2008-12-24 Ephrin type-a receptor 10 protein

Publications (2)

Publication Number Publication Date
JP2011509079A JP2011509079A (ja) 2011-03-24
JP2011509079A5 true JP2011509079A5 (enExample) 2012-02-16

Family

ID=40802031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010540186A Pending JP2011509079A (ja) 2007-12-24 2008-12-24 エフリンａ型受容体１０タンパク質

Country Status (4)

Country Link
US (1) US8540998B2 (enExample)
EP (1) EP2235055A2 (enExample)
JP (1) JP2011509079A (enExample)
WO (1) WO2009087462A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120231004A1 (en) * 2009-10-13 2012-09-13 Oxford Biotherapeutic Ltd. Antibodies
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
EP2496605A1 (en) 2009-11-02 2012-09-12 Oxford Biotherapeutics Ltd. Ror1 as therapeutic and diagnostic target
EP3211421A1 (en) 2010-09-09 2017-08-30 Traxxsson, LLC Combination methods of diagnosing cancer in a patient
WO2012124334A1 (ja) * 2011-03-15 2012-09-20 独立行政法人医薬基盤研究所 抗体、乳がんの治療に用いられる医薬組成物、腫瘍検査方法、及び、腫瘍検査用試薬
ME02632B (me) 2011-06-28 2017-06-20 Oxford Biotherapeutics Ltd Terapeutski i dijagnostički cilj
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
HRP20210410T1 (hr) 2013-10-11 2021-04-30 Oxford Bio Therapeutics Limited Konjugirana antitijela prema ly75 za liječenje raka
GB201703876D0 (en) 2017-03-10 2017-04-26 Berlin-Chemie Ag Pharmaceutical combinations
GB201809746D0 (en) 2018-06-14 2018-08-01 Berlin Chemie Ag Pharmaceutical combinations
WO2023088481A1 (en) * 2021-11-22 2023-05-25 China Medical University Antibody specific to ephrin type-a receptor 10, fusion protein containing the same, chimeric antigen receptor t-cell expressing the same and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096952A1 (en) 2000-03-30 2003-05-22 Kumud Majumder Novel proteins and nucleic acids encoding same
EP1303539B1 (en) * 2000-07-26 2004-11-24 MERCK PATENT GmbH A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
JP2003052384A (ja) * 2001-04-06 2003-02-25 Takeda Chem Ind Ltd 新規レセプタータンパク質及びそのｄｎａ
WO2006023420A2 (en) 2004-08-16 2006-03-02 Medimmune, Inc. Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity
EP2422811A2 (en) * 2004-10-27 2012-02-29 MedImmune, LLC Modulation of antibody specificity by tailoring the affinity to cognate antigens
AU2006287416A1 (en) * 2005-09-07 2007-03-15 Medimmune, Llc Toxin conjugated Eph receptor antibodies
JP2010511382A (ja) 2006-12-01 2010-04-15 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 癌関連タンパク質キナーゼ

Similar Documents

Publication Publication Date Title
JP2011509079A5 (enExample)
JP7674439B2 (ja) Ｇｆａｐとｕｃｈ－ｌ１との組合せを使用する、ヒト対象における外傷性脳損傷を診断及び査定する一助となるための方法
JP2010518847A5 (enExample)
Huang et al. Nanobodies®: proficient tools in diagnostics
JP6715770B2 (ja) モノクローナル抗ｔｋ１抗体
JP6180931B2 (ja) 癌の診断および／または予後のための新規な抗体
JP2008538289A5 (enExample)
JP2015172045A5 (enExample)
JP2018042573A5 (enExample)
JP2012523848A5 (enExample)
JP2013506428A5 (enExample)
JP2020522261A5 (enExample)
JP2015516985A5 (enExample)
JP2017518366A5 (enExample)
CN110720041A (zh) 用心肌肌钙蛋白i和早期生物标记物帮助诊断和评价人受试者中轻度创伤性脑损伤的方法
JP2013520174A5 (enExample)
JP2020534830A5 (enExample)
JP2016500659A5 (enExample)
JP2014529297A (ja) 新規な抗ｃｘｃｒ４抗体並びに癌の検出および診断のためのその使用
JP7252953B2 (ja) Ｈ１．０ｋ１８０ｍｅ２抗体、その作製および使用の方法
Kadonosono et al. Design strategy to create antibody mimetics harbouring immobilised complementarity determining region peptides for practical use
WO2015106311A1 (en) Cell surface prostate cancer antigen for diagnosis
JP2010535506A5 (enExample)
AU2016333540A1 (en) GDF-15 as a diagnostic marker for melanoma
US12055552B2 (en) Method for diagnosis based on circulating extracellular vesicles